Alterations in the relative abundance of Faecalibacterium prausnitzii correlate with changes in fecal calprotectin in patients with ileal Crohn's disease: a longitudinal study

被引:16
|
作者
Bjorkqvist, Olle [1 ]
Repsilber, Dirk [1 ]
Seifert, Maike [2 ]
Brislawn, Colin [3 ]
Jansson, Janet [3 ]
Engstrand, Lars [2 ]
Rangel, Ignacio [1 ]
Halfvarson, Jonas [4 ]
机构
[1] Orebro Univ, Sch Med Sci, Orebro, Sweden
[2] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
[3] Pacific Northwest Natl Lab, Earth & Biol Sci Directorate, Richland, WA 99352 USA
[4] Orebro Univ, Dept Gastroenterol, Fac Med & Hlth, SE-70182 Orebro, Sweden
关键词
Faecalibacterium prausnitzii; Crohn's disease; calprotectin; butyrate; dysbiosis; BUTYRATE-PRODUCING BACTERIA; ULCERATIVE-COLITIS; MICROBIAL ECOLOGY; QUANTITATIVE PCR; PATHOGENESIS; INFLAMMATION; METABOLISM; TWIN;
D O I
10.1080/00365521.2019.1599417
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Crohn's disease is characterized by a gut dysbiosis with decreased abundance of butyrate producers such as Faecalibacterium prausnitzii. Although F. prausnitzii secretes anti-inflammatory molecules, few studies have addressed the importance of F. prausnitzii in a longitudinal setting. We aimed to examine the relationship between temporal profiles of F. prausnitzii, the C. leptum group, overall butyrate production, and inflammatory activity. Material and methods: Fecal samples (n = 59) were collected every third month from nine patients with ileal Crohn's disease. The abundance of F. prausnitzii and C. leptum was quantified relative to the total amount of bacteria using quantitative-PCR. To assess butyrate production of gut microbiota, gene copy numbers of the butyryl-CoA:acetate-CoA transferase (BCoAT) gene were quantified by qPCR. The inflammatory activity was defined by fecal (f)-calprotectin. Results: No correlation between the relative abundance of F. prausnitzii, the C. leptum group, or copy numbers of the BCoAT gene, and f-calprotectin was observed in the total sample set. By analyzing alterations between consecutive samples, a negative correlation between changes in the relative abundance of F. prausnitzii and f-calprotectin was observed (R = -0.39; p = .009). Changes in C. leptum (R = -0.18, p = .23) and number of copies of the BCoAT gene (R = -0.12; p = .42) did not correlate with f-calprotectin. Conclusions: There was an inverse correlation between temporal changes in the relative abundance of F. prausnitzii, but not overall butyrate producing capacity, and changes in inflammatory activity in ileal Crohn's disease. These findings indicate that F. prausnitzii may play a role in gut homeostasis, even though causality is still to be demonstrated.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 50 条
  • [31] Fecal Calprotectin Diagnostic Level Gradient Along the Small Bowel in Patients With Crohn's Disease
    Ukashi, Offir
    Kopylov, Uri
    Ungar, Bella
    Talan Asher, Adi
    Shachar, Eyal
    Engel, Tal
    Albshesh, Ahmad
    Yablecovitch, Doron
    Lahat, Adi
    Eliakim, Rami
    Ben-Horin, Shomron
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [32] Ustekinumab levels correlate with induction fecal calprotectin drop-slope and discriminate the need for intensification at week 52 in Crohn's Disease patients
    Mateos, B.
    Saez-Gonzalez, E.
    Iborra, M.
    Moret, I.
    Canada, A.
    Tortosa, L.
    Bastida, G.
    Aguas, M.
    Cerrillo, E.
    Nos, P.
    Beltran, B.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S533 - S534
  • [33] Prediction of relapse using consecutive measurements of fecal calprotectin in pediatric Crohn's disease patients
    Foster, A. J.
    Jacobson, K.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S410 - S410
  • [34] LONGITUDINAL STUDY OF FAECAL MARKERS FOLLOWING ILEAL RESECTION IN CROHN'S DISEASE-DO CALPROTECTIN AND LACTOFERRIN NORMALISE POST OPERATIVELY?
    Lamb, C. A.
    Mohiuddin, M. K.
    Gicquel, J.
    Neely, D.
    Bergin, F. G.
    Hanson, J. M.
    Mansfield, J. C.
    GUT, 2009, 58 : A58 - A59
  • [35] Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study
    Kallel, Lamia
    Ayadi, Imen
    Matri, Samira
    Fekih, Monia
    Ben Mahmoud, Nadia
    Feki, Moncef
    Karoui, Sami
    Zouari, Bechir
    Boubaker, Jalel
    Kaabachi, Naziha
    Filali, Azza
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (03) : 340 - 345
  • [36] A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy
    Shitrit, Ariella Bar-Gil
    Koslowsky, Benjamin
    Livovsky, Dan M.
    Shitrit, David
    Paz, Kalman
    Adar, Tomer
    Adler, Samuel N.
    Goldin, Eran
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (03) : 328 - 333
  • [37] CHARACTERIZATION OF THE KEY ANTI-INFLAMMATORY BACTERIUM FAECALIBACTERIUM PRAUSNITZII INTERNATIONALLY IN HEALTH AND CROHN'S DISEASE. THE ENIGMA STUDY.
    Teh, Jing Jie
    Kang, Seungha
    Leonard, Alarna
    Zhang, Jingwan
    Hu, Jielun
    Hamilton, Amy L.
    Wilson-O'Brien, Amy
    Trakman, Gina L.
    Lin, Winnie Y.
    Ching, Jessica Y.
    Sung, Joseph Jy
    Yu, Jun
    Ng, Siew C.
    Kamm, Michael A.
    Morrison, Mark
    GASTROENTEROLOGY, 2023, 164 (06) : S920 - S920
  • [38] CORRELATION OF FECAL, PLASMA, SERUM, AND SALIVARY CALPROTECTIN TO ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN PATIENTS WITH CROHN'S DISEASE
    Kamp, Kendra
    Clark-Snustad, Kindra
    Saad, Kamil
    Tolentino, Ernie
    Heitkemper, Margaret
    Dey, Neelendu
    Gui, Sean
    Lee, Scott D.
    INFLAMMATORY BOWEL DISEASES, 2022, 28 : S32 - S32
  • [39] CORRELATION OF FECAL, PLASMA, SERUM, AND SALIVARY CALPROTECTIN TO ENDOSCOPIC AND HISTOLOGIC OUTCOMES IN PATIENTS WITH CROHN'S DISEASE
    Kamp, Kendra
    Clark-Snustad, Kindra
    Saad, Kamil
    Tolentino, Ernie
    Heitkemper, Margaret
    Dey, Neelendu
    Gui, Sean
    Lee, Scott D.
    GASTROENTEROLOGY, 2022, 162 (03) : S32 - S32
  • [40] Key Anti-Inflammatory Faecalibacterium prausnitzii is Heterogeneous and Diverse in the East and West and in Health and Crohn's disease. The ENIGMA study.
    Teh, J. J.
    Kang, S.
    Leonard, A.
    Zhang, J.
    Hu, J.
    Hamilton, A. L.
    Wilson-O'Brien, A.
    Trakman, G. L.
    Lin, W.
    Ching, J.
    Sung, J. J. Y.
    Yu, J.
    Ng, S. C.
    Kamm, M. A.
    Morrison, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I116 - I118